Table 2.
Univariate and multivariate analysis of clinical parameters of patients with HCC
| Clinical parameters | Uni-variate | Multi-variate | ||
|---|---|---|---|---|
| HR (95% CI) | P-value | HR (95% CI) | P-value | |
| Pathological stage ((III + IV)/(I + II)) | 1.403 (0.194–10.14) | 0.737 | 1.093 (0.143–8.264) | 0.932 |
| Intensity of infiltrating CD8+T cells (high/low) | 0.451 (0.255–0.798) | 0.006 | 0.470 (0.238–0.928) | 0.030 |
| Intensity of infiltrating CD103+ cells (high/low) | 0.754 (0.454–1.252) | 0.275 | 1.067 (0.576–1.978) | 0.826 |
| Intensity of infiltrating CD103+CD8+T cells (high/low) | 0.572 (0.289–1.133) | 0.109 | 0.791 (0.098–6.415) | 0.357 |
| Ratio of CD103+CD8+T cells over total CD8+T cells (high/low) | 0.558 (0.250–1.247) | 0.071 | 1.200 (1.523–9.441) | 0.862 |
Bold signifies P < 0.05